Searchable abstracts of presentations at key conferences in endocrinology

ea0081p141 | Pituitary and Neuroendocrinology | ECE2022

Bartter syndrome type I: a rare cause of polyuria-polydipsia syndrome with failure to thrive in a child

Barbacariu Ioana-Cristina , blesneac ilona-beatrice , Rosu Andreea , Protop Madalina , Munteanu Mihaela , Gorduza Eusebiu-Vlad , Preda Cristina

Introduction: Bartter syndrome (BS) is a rare autosomal recessive disorder, with an estimated prevalence of 1 in 1.000.000. It is characterized by a primary defect in sodium chloride reabsorption in the medullary thick ascending limb of Henle’s loop. Severe hypokalemia, metabolic alkalosis, hyponatremia, hypochloremia, hyperaldosteronism, and increased urinary loss of sodium, potassium, and chloride can raise the suspicion of BS, but genetic testing is required for a defi...

ea0081p402 | Pituitary and Neuroendocrinology | ECE2022

Central pontine myelinolysis: Case report

Gonzalez Lazaro Paloma , Contreras Pascual Cristina , Montalban Mendez Cristina , Moreno Tirado Antonio , Zhao Montero Benitez Maria , Jimenez Torrecilla Pedro

Introduction: Central pontine myelinolysis (CPM) is a rare and potentially life-threatening complication of a sudden rise in serum osmolality. Along with extrapontine myelinolysis, it is part of the osmotic demyelination syndrome (ODS). Known risk factors include severe hyponatremia, alcoholism, thiazide use, hypokalemia, and malnourishment.Case report: We report the case of a 31-year-old-male with history of alcohol and cannabis dependence, who had atte...

ea0081ep1206 | Late Breaking | ECE2022

The impact of gh treatment in turner syndrome

Hrisca Anamaria , Dumitru Teodora , Andrei Diana , Florescu Alexandru , Leustean Letitia , Rusu Cristina , Preda Cristina , Ungureanu Maria Christina

Introduction: The treatment with growth hormone (GH) plays an essential role in the Turner syndrome (TS) management. This study evaluated its efficacy in improving adult height (AH) and metabolic parameters.Material and methods: We retrospectively analysed auxological, biochemical, genetic and pharmacological parameters of 56 girls with confirmed TS. They were categorised according to their karyotype as X monosomy (62%), isochromosome (17%), X mosaicism ...

ea0084op-01-05 | Oral Session 1: Topic Highlights | ETA2022

Sarcopenia as a prognostic factor in patients with advanced thyroid cancer treated with tyrosine kinase inhibitors

Dalmiglio Cristina , Brilli Lucia , Ciuoli Cristina , Sannino Ida , Maino Fabio , Valerio Laura , Cartocci Alessandra , Grazia Castagna Maria

Objective: Recent studies have shown that sarcopenia at cancer diagnosis is associated with a poor survival in patients with solid tumors. Up to now, few data are available among patients with advanced thyroid cancer, especially those treated with tyrosine kinase inhibitors (TKI). We retrospectively evaluated sarcopenia by Skeletal Muscle Index (SMI) in a cohort of advanced thyroid cancer patients before and during TKI treatment and investigated its association with treatment ...

ea0063p498 | Calcium and Bone 2 | ECE2019

Bilateral femoral fractures in a pacient with primary hyperparathyroidism: A case report

Ioan Bianca , Ambarus Ioana , Feraru Laura , Chelaru Alina , Protop Madalina , Rosu Andreea , Neagu Georgiana , Grigorovici Alexandru , Ungureanu Cristina , Preda Cristina

Introduction: Primary hyperparathyroidism (PHPT) is a common endocrine disorder often diagnosed in asymptomatic individuals on routine biochemical screening, which, if left untreated, can have devastating consequences. The main target organs of PTH are the skeletal system and the kidneys. Asymptomatic hypercalcaemia in young adults is uncommon, and patients who remain asymptomatic should be monitored for the development of complications that justify surgery.<p class="abste...

ea0063p813 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Pituitary metastasis of Neuroendocrine Carcinoma – a rare case report

Castro Raquel , Macedo Daniel , Coiteiro Domingos , Vilela Pedro , Mafra Manuela , Pinto Cristina , Loewenthal Cristina , Nave Monica , Rosario Francisco

The authors report the clinical case of a 59-year old female who had vague complaints of impaired vision, fatigue and diffuse pain for more than a year before medical evaluation at our hospital. At the ophthalmology appointment, bitemporal hemianopsia was evident. Brain MRI was the diagnostic test of choice and revealed a mass involving de sellar and suprassellar space, causing compression of the optic chiasm, as well as osteolytic lesions in cranial vault. The patient was the...

ea0049ep1040 | Pituitary - Clinical | ECE2017

Radiological study of clinically non-functioning pituitary macroadenomas: a single institutional experience

Moreno Cristina , Paja Miguel , Lizarraga Aitzol , Etxeberria Eider , Arrizabalaga Cristina , Ugarte Estibaliz , Izuzquiza Ana , Goni Fernando , Iglesias Natalia , Calles Laura

Introduction: When facing with non-functioning pituitary macroadenomas (NFPMA), radiological invasion is determinant to surgical approach, apart from histological biomarkers of pituitary tumor aggressiveness (Ki-67; p53 and mitotic index). Invasive tumors usually need additional surgery and/or radiotherapy. There are no much studies describing epidemiological data on aggressive pituitary tumors in clinical practice. We provide information regarding the radiological findings of...

ea0037gp.15.02 | Diabetes and obesity – basic | ECE2015

Sex hormone-binding globulin protects against non-alcoholic fatty liver disease

Lopez Cristina Saez , Barbosa-Desongles Anna , Hernandez Cristina , Dyer Roger A , Innis Sheila M , Rafael Simo , Selva David M

Low plasma sex hormone-binding globulin (SHBG) levels are present in patients suffering chronic metabolic diseases, including non-alcoholic fatty liver disease (NAFLD). However, whether altered SHBG production plays a role in development and progression of this disease is unclear. To investigate SHBG involvement in NAFLD, we studied the effects of overexpressing SHBG in two mouse models, a genetically-induced model, by developing a double transgenic mouse by crossing the human...

ea0037ep635 | Obesity and cardiovascular endocrinology | ECE2015

Therapeutic education contributes to minimise excess weight in Prader-Willi syndrome

Stefan Roxana , Rusu Cristina , Armasu Ioana , Belceanu Alina , Braha Elena , Gorduza Carmen , Mihai Bogdan , Lacatusu Cristina , Negru Mihaela , Vulpoi Carmen

Introduction: Prader-Willi syndrome (PWS) is a complex genetic disorder characterised by hyperphagia with progressive obesity, dysmorphic features, hypotonia, mental retardation, behavioural abnormalities and endocrine dysfunctions as hypogonadism and growth hormone (GH) deficiency. PWS is the most commonly identified genetic cause of obesity.Methods: We reviewed five cases of confirmed PWS (three female and two male patients, aged between 8 and 32 years...

ea0035p246 | Clinical case reports Pituitary/Adrenal | ECE2014

Prepubertal male gynecomastia-issues of diagnosis

Hreniuc Ana , Gherasim Simona , Hristov Ioana , Preda Cristina , Vulpoi Carmen , Ungureanu Maria-Christina , Cristea Cristina , Mogos Voichita , Leustean Letitia

We present the case of 13 years old boy referred to our service in June 2013 for bilateral gynecomastia (appeared for ~1 year). The boy’s father presented delayed puberty (at 18-year-old). No other pathological hereditary conditions were reported.Clinical examination revealed: gynoid status with height =167 cm (−1.4 DS), weight=63.5 kg, important bilateral gynecomastia with hypo pigmented areola and painful palpation. Sexual development was PI...